Patents and Patent Applications from Northwestern University


Match Document Document Title
US20170358795 ELECTRODE MATERIAL COMPRISING GRAPHENE-COMPOSITE MATERIALS IN A GRAPHITE NETWORK  
A durable electrode material suitable for use in Li ion batteries is provided. The material is comprised of a continuous network of graphite regions integrated with, and in good electrical contact...
US20170355722 ARSENOPLATIN ANTI-CANCER AGENTS  
Disclosed herein are methods of treating a cancer cell that include contacting a cancer cell with a compound having the structure of formula (I) M is Pt, Pd or Ni; Q is As, Sb or Bi; Z1 is N; Z2...
US20170354711 HIGH DENSITY LIPOPROTEIN NANOPARTICLES FOR INFLAMMATION  
The invention in aspects relates to methods of treating sepsis using HDL-NP. The methods include the use of nanoparticles having a core and a lipid based shell with optimal lipids therein.
US20170354420 Intranasal Occlusion Device And Methods Of Using The Same  
An intranasal occlusion device having an inflatable balloon within a sponge that is used to prevent drainage of fluid, such as blood and other fluids into the airway during sinus and nasal minor...
9840634 High-resolution patterning of graphene by screen and gravure printing for highly flexible printed electronics  
Graphene ink compositions as can be utilized with gravure and screen printing processes, to provide flexible electronic components with high-resolution printed graphene circuitry.
9840487 Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compounds  
Methods to access 2-aryl chromene compounds via an asymmetric catalytic process.
9839625 Inhibition of cancer cell motility  
Provided herein are compositions and methods for inhibiting cancer cell motility and/or metastasis. In particular embodiments, KBU2046 (or an analog thereof) and one or more additional therapies...
US20170352151 Spatiotemporal Background Phase Correction For Phase Contrast Velocity Encoded MRI  
A computer-implemented method for performing spatiotemporal background phase correction for phase contrast velocity encoded magnetic resonance imaging includes performing a phase contrast magnetic...
US20170351318 SYSTEM AND METHOD FOR ASSOCIATIVE POWER AND CLOCK MANAGEMENT WITH INSTRUCTION GOVERNED OPERATION FOR POWER EFFICIENT COMPUTING  
A system includes an ARM core processor, a programmable regulator, a compiler, and a control unit, where the compiler uses a performance association outcome to generate a 2-bit regulator control...
US20170349928 METHODS FOR ACTIVATING NATURAL ENERGY METABOLISM FOR IMPROVING YEAST CELL-FREE PROTEIN SYNTHESIS  
Disclosed are compositions, methods, and kits for enhanced synthesis of a biological macromolecule in vitro using cell-free protein synthesis. The compositions, methods, and kits include or...
US20170349552 Treatment of Amyotrophic Lateral Sclerosis  
The present invention relates to the identification of compounds and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative...
9834693 Methods for preparation of concentrated graphene ink compositions and related composite materials  
A rapid, scalable methodology for graphene dispersion and concentration with a polymer-organic solvent medium, as can be utilized without centrifugation, to enhance graphene concentration.
US20170344119 HAPTIC TOUCH SCREEN AND METHOD OF OPERATING THE SAME  
A haptic touch screen including a lower layer including a plurality of control electrodes, an upper layer including a plurality of haptic electrodes, a middle layer between the lower layer and...
9832769 Virtual full duplex network communications  
A half-duplex wireless network device is structured to transmit and receive information over a unique pattern of one or more transmission slots and one or more reception slots within each of a...
9830501 High throughput partial wave spectroscopic microscopy and associated systems and methods  
The present technology provides methods, systems, and apparatuses to achieve high throughput and high speed acquisition of partial wave spectroscopic (PWS) microscopic images. In particular,...
9828371 Methods of making diazaperopyrenium dications and uses thereof  
Methods of making diazaperopyrenium dications with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone, and uses thereof are provided.
9828259 Excage: synthesis of viologen-like pyridinium-based cages for the selective capture of polycyclic aromatic hydrocarbons  
Compounds are provided for the capture of polycyclic aromatic hydrocarbons. The compound is selected from formula (I) and formula (II): The compound includes a salt formed with a suitable counter...
US20170335335 SYSTEMS AND METHODS FOR UNTARGETED METABOLOMIC SCREENING  
Provided herein are systems and methods for untargeted screening of metabolite products of biosynthetic gene clusters. In particular, systems and methods are provided for the detection of...
US20170332935 METHODS AND SYSTEMS FOR IDENTIFYING NON-PENETRATING BRAIN INJURIES  
The present disclosure provides methods for identifying non-penetrating brain injury in a subject, as well as methods for classifying a subject that received a hit to the body that transmitted an...
9825229 Purification of carbon nanotubes via selective heating  
The present invention provides methods for purifying a layer of carbon nanotubes comprising providing a precursor layer of substantially aligned carbon nanotubes supported by a substrate, wherein...
9816979 Devices and methods for filtering blood plasma  
The present invention provides systems, devices, kits, and methods for separating blood plasma from whole blood. In particular, the present invention provides systems, devices, and methods for...
9815764 Homochiral metal-organic framework with enantiopure pillar[5]arene active domains  
Homochiral metal organic framework (MOF) selected from a group consisting of (Sp)-P5A-MOF-1 and (Rp)-P5A-MOF-1 is provided. The homochiral MOFs are prepared from pure enantiomer struts of formula...
9815753 Supported metal oxides for olefin metathesis and related methods  
A method is provided comprising exposing a supported heterogeneous metathesis catalyst to an olefin compound for an activation time at an activation temperature; exposing the activated supported...
9815044 Ceria-supported metal catalysts for the selective reduction of NOX  
A composition and method for producing the same are provided. The composition includes transition metal oxides adhered to a surface of a cerium oxide support, and can additionally include alkali...
US20170319650 MASPIN-BASED INHIBITION OF OSTEOCLAST ACTIVITY AND PROMOTION OF BONE FORMATION  
Provided herein are compositions and methods for the treatment of bone disorders through the maspin-based inhibition of osteoclastogenesis and osteoclast activity and the promotion of bone formation.
9811194 Touch interface device and methods for applying controllable shear forces to a human appendage  
A touch interface device including a touch surface, a sensor, one or more actuators, and a plurality of electrodes is disclosed. The sensor measures a plurality of locations when the touch surface...
9809556 Treatment of amyotrophic lateral sclerosis  
The present invention relates to the identification of compounds and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative...
US20170313747 SELF-ASSEMBLED NANOSTRUCTURES  
The present disclosure is directed to the preparation of nanostructures by the encapsulation of a charged compound with individual self-assembled unit nanostructures.
US20170312365 SHORT INTERFERING RNA TEMPLATED LIPOPROTEIN PARTICLES (SIRNA-TLP)  
Nanostructures for the systemic delivery of nucleic acids, such as RNA, are provided herein. The nanostructures include templated lipoprotein nanoparticles (TLPs) composed of a core decorated with...
US20170312349 PEPTIDE CONJUGATED PARTICLES  
The present invention provides compositions comprising peptide-coupled biodegradable poly(lactide-co-glycolide) (PLG) particles. In particular, PLG particles are surface-functionalized to allow...
US20170312284 ANALOGS OF ADENOSINE MONOPHOSPHATE (AMP) AS INHIBITORS OF UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME ATG7  
Disclosed are analogs of adenosine monophosphate (AMP) as inhibitors of ubiquitin-like modifier-activing enzyme ATG7. The AMP analogs may be formulated as pharmaceutical compositions for treating...
9804724 Haptic device with indirect haptic feedback  
An indirect haptic device having a substrate having a touch surface, a position sensor of a user's clothed appendage relative to the touch surface, a friction modulator associated with the...
9803136 Liquid electrolyte-free, solid-state solar cells with inorganic hole transport materials  
Photovoltaic cells incorporating the compounds A/M/X compounds as hole transport materials are provide. The A/M/X compounds comprise one or more A moieties, one or more M atoms and one or more X...
9802946 NMDA receptor modulators and uses thereof  
Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of diseases and disorder such as learning,...
9802942 Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity  
Disclosed are new small molecules having a 4-methylpyrrrolo[1,2-a]pyrimidine-8-carboxamide core structure and the uses thereof for modulating glucocerebrosidase activity. Also disclosed are...
9802818 Sorting process of nanoparticles and applications of same  
In one aspect of the present invention, a method for sorting nanoparticles includes preparing a high-viscosity density gradient medium filled in a container, dispersing nanoparticles into an...
9801952 Magnetic nanostructures as theranostic agents  
The present invention relates to magnetic nanostructures as theranostic agents, which provide dual function as diagnostic and therapeutic agents. In particular, the present invention relates to...
9801738 Liquid cast biodegradable arterial stent  
Disclosed are liquid cast biodegradable arterial stents and methods for preparing liquid cast biodegradable arterial stents. The typically includes a biodegradable polymer and may include an agent...
US20170309747 SYSTEM AND METHOD FOR THRESHOLD LOGIC WITH ELECTROSTATICALLY FORMED NANOWIRE TRANSISTORS  
An electrostatically formed nanowire transistor, includes a source, a drain, and multiple gates surrounding a doped silicon region. The gates include a top gate, a bottom gate, and side gates. The...
US20170308597 SYSTEMS AND METHODS FOR ENABLING SITUATIONAL AWARENESS FOR EVENTS VIA DATA VISUALIZATION  
Aspects of the present disclosure relate to data visualization, and more specifically, to technology that automatically visualizes various analytics and predictions generated for mass...
US20170307440 DEVICES, METHODS, AND SYSTEMS RELATING TO SUPER RESOLUTION IMAGING  
Certain examples disclose systems and methods for imaging a target. An example method includes: a) activating a subset of light-emitting molecules in a wide field area of a target using an...
US20170306320 METHODS FOR IN VITRO RIBOSOME SYNTHESIS AND EVOLUTION  
Disclosed are methods, components, compositions, and kits for preparing and identifying engineered E. coli ribosomes. The E. coli ribosomes may be prepared and identified under a set of defined...
US20170306258 LUBRICANT ADDITIVES, LUBRICANT COMPOSITIONS, AND APPLICATIONS OF SAME  
A lubricant composition includes a base lubricant and a plurality of lubricant additive molecules. Each lubricant additive molecule includes a surface active group attractable to a target surface,...
US20170305998 MODIFIED PIGMENT EPITHELIUM-DERIVED FACTOR (PEDF) PEPTIDES AND USES THEREOF FOR TREATING NEOVASCULAR DISEASES, INFLAMMATORY DISEASES, CANCER, AND FOR CYTOPROTECTION  
Disclosed are modified pigment epithelium-derived factor (PEDF) peptides, particulate carrier prodrugs thereof, and pharmaceutical compositions comprising the peptides or particulate carrier...
US20170305901 THERAPEUTIC TARGETING OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4 (IRAK4) IN CANCERS CHARACTERIZED BY REARRANGEMENTS IN THE MIXED LINEAGE LEUKEMIA GENE (MLL-r)  
Disclosed are methods for treating cancers associated with rearrangements in the mixed lineage leukemia gene (MLL-r), including MLL-r leukemia. The methods typically include administering a...
US20170305813 Sulfur as a Selective Oxidant in Oxidative Hydrocarbon Processing Over Oxide/Chalcogenide Catalysts  
Methods for oxidative coupling of methane using metal oxide catalysts and a sulfur oxidant.
US20170304587 PHASE-LOCKED LOOP TO ENHANCE SLOW WAVE SLEEP  
Certain examples provide systems and methods to enhance slow wave sleep. An example method includes identifying a sleep stage for slow wave sleep in a subject being monitored. The example method...
US20170304232 Endoxifen For Local Transdermal Therapy To The Breast  
Disclosed are methods and topical formulations for treating and/or preventing cell proliferative diseases and disorders including breast cancer and ductal carcinoma is situ (DCIS) using local...
9797030 Aluminum alloy with additions of scandium, zirconium and erbium  
An aluminum alloy including additions of scandium, zirconium, erbium and, optionally, silicon.
9796755 Methods of treating depression and other related diseases  
The invention relates to methods for treating depression, anxiety, and other related diseases by administering a peptide NMDAR partial agonist.